Effect of the Transmuscular Quadratus Lumborum Block on Duration of Stay in Recovery (TQL_PACU)

Zealand University Hospital

Status: Unknown

Conditions: Anesthesia, Local

Treatments: Drug: Ropivacaine injection

Study type: Observational

Funder types: Other

Identifiers

NCT04951752

SOPRE-001

Details and patient eligibility

About

The study will review data collected in 5 previously completed randomised controlled trials with a new primary outcome: to assess whether administration of the transmuscular quadratus lumborum block has an impact on the time an individual patient stays in the postanaesthesia care unit and how much opioid is consumed during this specified time.

Enrollment: 307 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Elective Surgery

Exclusion criteria

• Inability to cooperate
• Allergy to local anaesthetics or opioids
• Inability to understand Danish
• Regular intake of opioids
• Local infection at site of injection

Trial design

307 participants in 10 patient groups

Hemicolectomy, Active treatment

Description:

2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block

Treatment:

Drug: Ropivacaine injection

Hemicolectomy, Placebo treatment

Description:

2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block

Nephrectomy, Active treatment

Description:

2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block

Treatment:

Drug: Ropivacaine injection

Nephrectomy, Placebo treatment

Description:

2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block

Percutaneous nephrolithotomy, Active treatment

Description:

1x30mL 0.75% Ropivacaine administered by way of transmuscular quadratus lumborum block

Treatment:

Drug: Ropivacaine injection

Percutaneous nephrolithotomy, Placebo treatment

Description:

1x30mL isotonic saline administered by way of transmuscular quadratus lumborum block

Hysterectomy, Active treatment

Description:

2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block

Treatment:

Drug: Ropivacaine injection

Hysterectomy, Placebo treatment

Description:

2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block

Elective Caesarean section, Active treatment

Description:

2x30mL 0.375% Ropivacaine administered by way of transmuscular quadratus lumborum block

Treatment:

Drug: Ropivacaine injection

Elective Caesarean section, Placebo treatment

Description:

2x30mL isotonic saline administered by way of transmuscular quadratus lumborum block